Friday, March 11, 2022

Capricor culls COVID-19 vax work but eyes phase 3 for Duchenne therapy | Fierce Biotech

Marb├ín and McDonald could see Capricor's cell therapy one day being paired with a gene therapy for the disease. Preclinical studies have shown ...
https://www.google.com/url?rct=j&sa=t&url=https://www.fiercebiotech.com/biotech/capricor-begin-enrolling-phase-3-dmd-trial-next-quarter-halts-work-mrna-covid-19-vax&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGlVSNF-dF8xGzE_EArXBc1n0PcMw

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...